In February 2024, when she was five, Liliana was diagnosed with Morquio syndrome — also known as mucopolysaccharidosis type ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

For the first time, Hospital Kuala Lumpur (HKL) is proudly hosting the annual Rare Disease Day 2025 celebration to raise ...

Detailed price information for Biomarin Pharmaceuticals (BMRN-Q) from The Globe and Mail including charting and trades.

The enzyme replacement therapy (ERT) market is projected to grow significantly, rising from US$ 10,707.6 million in 2024 to US$ 20,289.1 million by 2034, at a robust CAGR of 6.60% over the forecast ...